ProveIt Supplements

Independent, evidence-based supplement analysis.

✓ Not Sponsored

✓ No Paid Reviews

✓ Science-Based

Company

  • About Us
  • Our Methodology
  • Contact
  • Blog
  • Authors

Legal

  • Privacy Policy
  • Terms of Service
  • Medical Disclaimer
  • Affiliate Disclosure

Resources

  • All Categories
  • Ingredient Database
  • Browse Supplements
  • FAQ

© 2025 ProveIt Supplements. All rights reserved.

Medical Disclaimer: The information provided is for educational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional before starting any supplement regimen.

Prove It
Browse SupplementsBlogAuthorsAboutMethodologyFAQ
Get Your Personalized Supplement StackSupplement Stack Quiz
Menu
HomeBrowse SupplementsBlogAuthorsAboutMethodologyFAQ
Back

Poria Paradicis Extract

Also known as: Poria cocos (Schw.) Wolf, Wolfiporia cocos, Fuling, Hoelen, Poria, Poria Paradicis Extract, Poria cocos

Overview

Poria cocos, commonly known as Fuling or Hoelen, is a medicinal fungus that grows on the roots of pine trees, primarily in East Asia. It is a cornerstone ingredient in Traditional Chinese Medicine (TCM) and other traditional healing systems, valued for its diuretic, sedative, and tonic properties. The extract, often mistakenly referred to as "Poria Paradicis Extract," contains bioactive compounds such as triterpenoids (e.g., pachymic acid, dehydrotumulosic acid) and polysaccharides. While it can be used as a single extract, Poria cocos is frequently incorporated into multi-herb formulations. Research indicates its potential as an adjunct therapy for metabolic disorders like type 2 diabetes, for cancer support, and for improving sleep quality. The evidence base for Poria cocos is moderate, with many clinical studies focusing on multi-herb preparations rather than the isolated ingredient, suggesting a need for more high-quality research on its standalone effects.

Benefits

Poria cocos offers several evidence-based benefits, primarily as an adjunct therapy. For Type 2 Diabetes, meta-analyses show that Poria cocos (Fuling) formulae, when added to conventional hypoglycemic agents, significantly reduce fasting blood glucose (mean difference [MD] -0.82 mmol/L), 2-hour postprandial blood glucose (MD -1.15 mmol/L), and HbA1c (MD -0.64%). These reductions, observed over 8-12 weeks, are modest but statistically significant and clinically meaningful, particularly in Asian populations. In Cancer Support, Poria cocos-based formulae combined with chemotherapy have been shown to improve the quality of life in ovarian cancer patients, though specific effect sizes are not well-quantified. Preliminary clinical studies also suggest potential improvements in suboptimal sleep quality, although robust randomized controlled trials (RCTs) are currently lacking. While in vitro and animal studies indicate neuroprotective effects through modulation of Rho signaling, their clinical relevance remains unclear. The strength of evidence for these benefits is generally low to moderate, with many studies at risk of bias, highlighting the need for further rigorous research.

How it works

Poria cocos exerts its effects primarily through its active compounds, including polysaccharides and triterpenoids. In the context of glucose metabolism, these compounds are believed to enhance insulin sensitivity and reduce inflammation, contributing to improved glycemic control in type 2 diabetes. For cancer support, Poria cocos may offer immunomodulatory and anti-inflammatory effects, with network pharmacology suggesting interactions with multiple signaling pathways involved in cancer progression. Its potential neuroprotective and sedative effects are linked to the modulation of RhoA, CDC42, and actin cytoskeleton pathways in neuronal and glial cells. While the exact pharmacokinetics are not fully characterized, it is understood that both polysaccharides and triterpenoids are absorbed to some extent, allowing them to interact with various body systems, including metabolic, immune, and nervous systems.

Side effects

Poria cocos is generally considered well-tolerated, with adverse events being rare and typically mild. No common side effects (occurring in over 5% of users) have been reported in clinical studies. Uncommon side effects (1-5% frequency) may include mild gastrointestinal discomfort in some individuals. Rare side effects (less than 1%) could potentially involve allergic reactions, though these are not commonly documented. There are no significant drug interactions reported, but caution is advised when Poria cocos is used concurrently with hypoglycemic agents due to the potential for additive effects on blood glucose levels, which could lead to hypoglycemia. No specific contraindications have been established, other than a known allergy to the fungus. Data on its safety in special populations such as pregnant or lactating women and children are limited, thus its use in these groups should be approached with caution and under medical supervision.

Dosage

The optimal dosage for Poria cocos is not definitively established, as most clinical studies have utilized it as part of multi-herb formulations rather than as an isolated extract. However, typical doses observed in research range from 3 to 15 grams per day of dried Poria cocos or an equivalent extract. There is no established maximum safe dose, and no toxicity has been reported at these clinical dosages. Poria cocos is generally recommended to be taken with meals to minimize any potential gastrointestinal discomfort. It is available in various forms, including dried powder, water extract, or as an ingredient in complex herbal formulas. The absorption of its active components, such as polysaccharides and triterpenoids, varies, with triterpenoids potentially having better bioavailability. No specific cofactors are identified as necessary for its efficacy.

FAQs

Is 'Poria Paradicis Extract' the correct name for this supplement?

No, 'Poria Paradicis' is likely a misspelling or mislabeling. The correct scientific name for this medicinal mushroom is Poria cocos, also known as Fuling or Hoelen.

How should I take Poria cocos for best results?

Poria cocos is typically taken with meals to help minimize any potential gastrointestinal discomfort. Dosage varies, but clinical studies often use 3-15 grams per day of the dried mushroom or equivalent extract, often as part of multi-herb formulas.

Is Poria cocos safe to use with my diabetes medication?

Poria cocos may have additive effects with hypoglycemic agents, potentially lowering blood glucose further. While generally safe, it's crucial to monitor your blood sugar closely and consult your doctor to adjust medication if needed.

What kind of benefits can I expect from Poria cocos?

In type 2 diabetes, you might see modest improvements in blood glucose and HbA1c when used as an adjunct. For cancer patients, it may improve quality of life when combined with chemotherapy. Some also report better sleep quality.

Why is most research on multi-herb formulas rather than isolated Poria cocos?

Poria cocos is a traditional Chinese medicine herb, and TCM often uses synergistic multi-herb formulations. This means most clinical studies have focused on these complex formulas, making it harder to isolate the effects of Poria cocos alone.

Research Sources

  • https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0278536 – This systematic review and meta-analysis of 73 RCTs (6,489 participants) found that adding Poria cocos (Fuling) formulae to hypoglycemic agents significantly reduced fasting blood glucose, 2-hour postprandial blood glucose, and HbA1c in type 2 diabetes patients. The study noted that adverse events were not increased, but acknowledged that most included studies had a risk of bias, leading to low to moderate strength of evidence.
  • https://pmc.ncbi.nlm.nih.gov/articles/PMC9296330/ – This preclinical study investigated the effects of Poria cocos extract on neuronal and glial cells. It found that the extract could reverse MK-801-induced changes in cell migration and cytoskeletal organization, suggesting potential neuroprotective properties. However, as this was an in vitro and animal study, its direct clinical relevance to human outcomes is currently unclear.
  • https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.788810/full – This meta-analysis and network pharmacology study explored the role of Poria cocos-based formulae in ovarian cancer. It concluded that these formulae, when combined with chemotherapy, improved the quality of life in ovarian cancer patients. The network pharmacology analysis also suggested that Poria cocos interacts with multiple molecular targets, indicating complex mechanisms of action, though the study noted limitations due to a limited number of high-quality RCTs and unquantified effect sizes.